Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991939 · ClinicalTrials.gov registry record · Phase 3
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
A Phase 3 study, sponsored by Carelon Research.
- Terminated
- Registry status
- Phase 3
- Development phase
- 8
- Enrollment target
NCT00991939: Clinical Trial Phase 3 study, sponsored by Carelon Research.
NCT00991939 is a Phase 3 study that was terminated before completion, run by Carelon Research. The registered enrollment target is 8 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991939, a Phase 3 study, was terminated before completion, sponsored by Carelon Research.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will compare treatment with 3 courses of high-dose dexamethasone versus treatment with prednisone, for patients recently diagnosed with immune thrombocytopenic purpura (ITP). The primary hypothesis is that patients treated with high-dose dexamethasone will obtain a more durable remission than patients treated with prednisone.
Interventions
- DRUG Prednisone
- DRUG Dexamethasone USP Micronized
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
Why NCT00991939 stopped before completion
NCT00991939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT00991939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991939 about?
NCT00991939 is a clinical study titled "Initial Treatment of Patients With Immune Thrombocytopenic Purpura". This study will compare treatment with 3 courses of high-dose dexamethasone versus treatment with prednisone, for patients recently diagnosed with immune thrombocytopenic purpura (ITP). The primary hypothesis is that patients treated with high-dose dexamethasone will obtain a more durable remission ...
What is the current status of trial NCT00991939?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 8 participants. The study started on 2010-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00991939?
The interventions under investigation include: Prednisone (DRUG), Dexamethasone USP Micronized (DRUG).
Who is sponsoring clinical trial NCT00991939?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00991939's enrollment target sits among peer trials
8 1993rd of 2000 higher than 6 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia